Support WBURDrugs For Rare Diseases Have Become Uncommonly Rich MonopoliesPlay05:26Download AudioSydney LupkinJanuary 17, 2017 Share (Evaluate Pharma analysis for Kaiser Health News on Sept. 21, 2016)